Humira will be available on TrumpRx at an 86% discount, according to media reports, as part of AbbVie's deal with the White House to avoid tariffs. The news comes less than a week after the president ...
Humira (adalimumab) is a long-term maintenance medication used to manage chronic conditions like Crohn’s disease and rheumatoid arthritis. For many people, this drug is not a short-term fix but a ...
The TrumpRx site now lists more than 61 discounted medications from 11 drugmakers, up from about 40 when it launched in February.
Two more drug-making giants, Abbvie and Genentech, will start selling popular medications on the White House's discounted ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Biosimilars are gradually making inroads in the outpatient drug ...
The first biosimilars referencing Humira became available in 2023. That year, 10 FDA-approved adalimumab are now on the ...
The last time I spoke about AbbVie Inc. (ABBV) it was in a Seeking Alpha article entitled as "AbbVie: Increased Outlook For 2025 And Expansions Merit Continued 'Strong Buy' Rating." For this article I ...
When the Trump administration announced its Most Favored Nation policy, it was portrayed as a simple, sensible idea. Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results